Nasal inflammation response to endotoxin in people with asthma
Part of Blood & lymphatic, Immune system & allergy, Lungs & breathing clinical trials.
This study tests how the inside of your nose reacts to a substance called endotoxin (a germ-like particle that triggers inflammation). It may help us understand asthma better and could lead to better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with asthma by a doctor (or be a healthy person without asthma).
- You must be free of any cold, flu, or asthma flare-up for at least 4 weeks.
- You cannot have had nasal surgery, a hole in your septum, or nasal polyps.
- You must not have heart disease or any other chronic systemic illness.
- You cannot have a bleeding disorder or take blood thinners or antiplatelet drugs.
- You must not be immunocompromised (e.g., from HIV, low immunoglobulins, or immunosuppressive drugs, except corticosteroids).
- You must not have used tobacco or marijuana in the last 2 months, and your smoking history must be under 10 pack-years.
- You cannot be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how your immune system (your body’s defense system) reacts to a controlled substance that triggers inflammation. It may help researchers understand why some people have stronger or weaker inflammatory responses.
This study looks at different “immune inflammation patterns” in people with asthma and/or nasal polyps. It may help researchers better tailor future treatments by figuring out which patterns go with which symptoms.
This study looks at how eosinophils (a type of white blood cell) work in asthma, including in people who have not responded to certain biologic treatments. By joining, you may help researchers understand asthma better and potentially improve future treatments.
This study looks at the tiny germs in your airways (airway microbiota) to better understand different asthma “types” and what might drive symptoms. It may help researchers find more personalized approaches to asthma care by learning how lung bacteria relate to your asthma features.
This trial tests if seeing a lung specialist and an ear-nose-throat doctor together in one visit helps people with asthma and chronic sinusitis (with nasal polyps) feel better than seeing each specialist separately. You may qualify if your asthma or sinusitis is not well-controlled and you've used steroid pills in the past year.
This study tests how your lungs’ immune cells respond after a controlled exposure to endotoxin. It may help researchers understand and prevent harmful lung inflammation, even though it is a short, research-focused intervention.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.